Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HVPG”

34 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 34 results

Not applicableLooking for participantsNCT06863012
What this trial is testing

EUS-guided Portal Pressure Gradient (PPG) Measurement: a Potential Alternative to the Traditional HVPG

Who this might be right for
Portal HypertensionChronic Liver Disease (CLD)Cirrhosis
Fundacio Privada Mon Clinic Barcelona 20
Not applicableLooking for participantsNCT06205992
What this trial is testing

3D-MRE and 2D-MRE for Assessing Cirrhosis and Portal Hypertension

Who this might be right for
CirrhosisLiver Portal Hypertension
Shengjing Hospital 100
Not applicableStudy completedNCT06216509
What this trial is testing

Endoscopic Ultrasound-Guided Portosystemic Pressure Gradient Measurements

Who this might be right for
CirrhosisVascular Diseases
Institutul Regional de Gastroenterologie & Hepatologie Prof. dr. Octavian Fodor 50
Testing effectiveness (Phase 2)Ended earlyNCT01672879
What this trial is testing

Simtuzumab (SIM, GS-6624) in the Treatment of Cirrhosis Due to NASH

Who this might be right for
Liver Fibrosis Due to NASH
Gilead Sciences 259
Not applicableUnknownNCT03933891
What this trial is testing

Magnetic Resonance Technics for the Assessment of Liver Function Before and After TIPS

Who this might be right for
Liver CirrhosisTransjugular Intrahepatic Portosystemic Shunt (TIPS)Functional Magnetic Resonance Imaging
West China Hospital 200
Not applicableUnknownNCT05704192
What this trial is testing

CT-based HVPG Assessment for Predicting the Prognosis of HCC With TACE (CHANCE-CHESS 2302)

Who this might be right for
Hepatocellular CarcinomaPortal Hypertension
Zhongda Hospital 373
Not applicableUnknownNCT03687216
What this trial is testing

HVPG-Guided Therapy Versus EVL Plus NSBB in Second Prophylaxis of Esophageal Variceal Bleeding

Who this might be right for
Esophageal Varices in Cirrhosis of the Liver
West China Hospital 160
Post-approval studies (Phase 4)UnknownNCT02638415
What this trial is testing

The Effect of Hepatic Vein Pressure Gradient(HVPG)-Guided Therapy in Cirrhotic Patients With Esophagogastric Varices

Who this might be right for
Gastroesophageal VaricesCirrhosis
Shanghai Zhongshan Hospital 500
Large-scale testing (Phase 3)Study completedNCT02523196
What this trial is testing

Correlation and Comparison of the HepQuant® Disease Severity Index (DSI) With Hepatic Venous Pressure Gradient (HVPG)

Who this might be right for
Liver Disease
University of Colorado, Denver 20
Not applicableLooking for participantsNCT07424963
What this trial is testing

Hepatic Venous Pressure Gradient Versus Endoscopic Ultrasound-Guided Portal Pressure Gradient - Comparative Analysis (HEPCA)

Who this might be right for
CirrhosisPortal HypertensionEUS+3 more
Military University Hospital, Prague 40
Early research (Phase 1)Study completedNCT01851252
What this trial is testing

MBT Versus HVPG in Identifying Responders to Portal Hypertension Therapy

Who this might be right for
Chronic Liver DiseaseCirrhosisEsophageal Varices+2 more
Meridian Bioscience, Inc. 19
Not applicableLooking for participantsNCT05475015
What this trial is testing

3D-MRE for Assessing Cirrhosis, Advanced Chronic Liver Disease and Portal Hypertension

Who this might be right for
Cirrhosis, LiverPortal HypertensionAdvanced Chronic Liver Disease
Shengjing Hospital 150
Testing effectiveness (Phase 2)Ended earlyNCT03827200
What this trial is testing

A Study Evaluating the Utility of Ambrisentan in Lowering Portal Pressure in Patients With Liver Cirrhosis

Who this might be right for
CirrhosisPortal HypertensionAscites
Noorik Biopharmaceuticals AG 19
Not applicableStudy completedNCT04455464
What this trial is testing

Effect of Midodrine on HVPG in Advanced Chronic Liver Disease

Who this might be right for
Chronic Liver Disease
Institute of Liver and Biliary Sciences, India 60
Large-scale testing (Phase 3)Study completedNCT02134626
What this trial is testing

Simvastatin Effect on Portal Hypertension

Who this might be right for
Portal HypertensionEsophageal VaricesLiver Cirrhosis
Universidade Federal do Rio de Janeiro 34
Not applicableUnknownNCT03315767
What this trial is testing

Spleen-ARFI-assisted-Portal-Hypertension-Evaluation-Study (SAPHES)

Who this might be right for
Hypertension, Portal
University of Ulm 45
Not applicableUnknownNCT04797910
What this trial is testing

Effect of Antiviral Therapy on HVPG in Patients With Viral Cirrhosis

Who this might be right for
Portal Hypertension
Nanfang Hospital, Southern Medical University 24
Not applicableUnknownNCT01756859
What this trial is testing

MRI in Portal Hypertension

Who this might be right for
Portal Hypertension
University of Nottingham 49
Not applicableStudy completedNCT05689268
What this trial is testing

EUS-PPG vs HVPG in Portal Hypertension

Who this might be right for
CirrhosisPortal Hypertension
Hospital General Universitario de Alicante 33
Not applicableLooking for participantsNCT06513195
What this trial is testing

EUS-guided Response Assessment to NSBB

Who this might be right for
Portal Hypertension Related to Cirrhosis
Universitaire Ziekenhuizen KU Leuven 24
Load More Results